melatonin - CISMeF

Preferred Label : melatonin;

MeSH definition : A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.;

CISMeF synonym : n-(2-(5-methoxyindol-3-yl)ethyl)acetamide;

MeSH CAS label : acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-;

MeSH Related Number : 73-31-4 (Melatonin);

Registry Number MeSH : 73-31-4;

Wikipedia link : https://en.wikipedia.org/wiki/Melatonin;

Codes EINECS : 200-797-7;

Is substance : O;

UNII : JL5DK93RCL;

InChIKey : DRLFMBDRBRZALE-UHFFFAOYSA-N;

Details

Origin ID

D008550;

UMLS CUI

C0025219;

ATC code(s)
- melatonin [ATC Code]
- melatonin receptor agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- melatonin [Substance BNPC]
Currated CISMeF NLP mapping
- Melatonin [LOINC component]
- Melatonin [NCIt concept]
- Melatonin [FMA entity]
- Melatonin (substance) [SNOMED CT concept]
- melatonin [SNOMED Notion]
Indexing information
- 5-sulfatoxy-N-acetylserotonin [MeSH Supplementary Concept]
- N-((1-(4-chlorobenzyl)-4-methoxy-1H-indol-2-yl)methyl)propanamide [MeSH Supplementary Concept]
- N-(2-(1-naphthalenyl)ethyl)cyclobutanecarboxamide [MeSH Supplementary Concept]
- N-pentanoyl-2-benzyltryptamine [MeSH Supplementary Concept]
- S 20304 [MeSH Supplementary Concept]
- S 22153 [MeSH Supplementary Concept]
- agomelatine [MeSH Supplementary Concept]
Pharmacological action(s)
- antioxidants [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
Record concept(s)
- melatonin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-acetyl-1,2,3,3a,8,8a-hexahydro-8a-hydroxy-5-methoxypyrrolo(2,3-b)indole [MeSH Supplementary Concept]
- 2,3-dihydromelatonin [MeSH Supplementary Concept]
- 2-bromomelatonin [MeSH Supplementary Concept]
- 2-chloromelatonin [MeSH Supplementary Concept]
- 2-iodomelatonin [MeSH Supplementary Concept]
- 2-methyl-6,7-dichloromelatonin [MeSH Supplementary Concept]
- 2-phenylmelatonin [MeSH Supplementary Concept]
- 3-(acetylaminomethyl)-2-(ethoxycarbonyl)-6-methoxy-1,3,4,5-tetrahydrobenzo(cd)indole [MeSH Supplementary Concept]
- 4,6-difluoromelatonin [MeSH Supplementary Concept]
- 4-azamelatonin [MeSH Supplementary Concept]
- 4-hydroxymelatonin [MeSH Supplementary Concept]
- 5-methoxy-N-isobutanoyltryptamine [MeSH Supplementary Concept]
- 5-methoxyluzindole [MeSH Supplementary Concept]
- 6-chloromelatonin [MeSH Supplementary Concept]
- 6-fluoromelatonin [MeSH Supplementary Concept]
- 6-hydroxymelatonin [MeSH Supplementary Concept]
- 6-hydroxymelatonin glucuronide [MeSH Supplementary Concept]
- 6-sulfatoxymelatonin [MeSH Supplementary Concept]
- 7-azamelatonin [MeSH Supplementary Concept]
- ITH12674 [MeSH Supplementary Concept]
- N-(2-(1-((3-(2-(acetylamino)ethyl)-5-methoxy-1H-indol-2-yl)methyl)-5-methoxy-1H-indol-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-(4-chlorophenyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-(4-cyanobenzoyl)-5-methoxy-1H-indole-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-acetyl-5-methoxy-1H-indol-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(1-benzoyl-5-methoxy-1H-indol-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(5-methoxy-2-oxo-2,3-dihydro-1H-indol-3-yl)ethyl)acetamide [MeSH Supplementary Concept]
- N-(4-chlorobenzoyl)melatonin [MeSH Supplementary Concept]
- N-butanoyl-5-methoxytryptamine [MeSH Supplementary Concept]
- N1-nitrosomelatonin [MeSH Supplementary Concept]
- benzyl-tribromomelatonin [MeSH Supplementary Concept]
- beta-methyl-6-chloromelatonin [MeSH Supplementary Concept]
- melatoninolipoamide [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Melatonin Measurement [NCIt concept]
- Product containing melatonin (medicinal product) [SNOMED CT concept]
- Therapeutic Melatonin [NCIt concept]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Melatonin [FMA entity]
- Melatonin [NCIt concept]
- Melatonin [LOINC component]
- Melatonin (substance) [SNOMED CT concept]
- Product containing melatonin (medicinal product) [SNOMED CT concept]
- melatonin [ATC Code]
- melatonin [Substance BNPC]
- melatonin [SNOMED Notion]
Validated automatic mappings to BTNT
- melatonin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients